- Home
- ICCM vs JMM Comparison
ICCM vs JMM Comparison
Compare ICCM & JMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | ICCM | JMM |
|---|---|---|
| Founded | 2006 | 1988 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Trusts Except Educational Religious and Charitable |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.5M | 58.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ICCM | JMM |
|---|---|---|
| Price | $0.69 | $6.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 385.9K | 16.1K |
| Earning Date | 11-19-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.44% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,975,000.00 | N/A |
| Revenue This Year | $13.67 | N/A |
| Revenue Next Year | $38.55 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.59 | $5.29 |
| 52 Week High | $1.66 | $6.10 |
Technical Indicators
Market Signals| Indicator | ICCM | JMM |
|---|---|---|
| Relative Strength Index (RSI) | 41.57 | 42.49 |
| Support Level | $0.67 | $6.06 |
| Resistance Level | $0.73 | $6.15 |
| Average True Range (ATR) | 0.04 | 0.04 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 61.06 | 31.93 |
Price Performance
Historical ComparisonAbout ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
About JMM Nuveen Multi-Market Income Fund (MA)
Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities, including, but not limited to, residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.